234 related articles for article (PubMed ID: 7601145)
21. Prepeptide sequence of cinnamycin (Ro 09-0198): the first structural gene of a duramycin-type lantibiotic.
Kaletta C; Entian KD; Jung G
Eur J Biochem; 1991 Jul; 199(2):411-5. PubMed ID: 2070795
[TBL] [Abstract][Full Text] [Related]
22. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation.
Meyer HE; Heber M; Eisermann B; Korte H; Metzger JW; Jung G
Anal Biochem; 1994 Dec; 223(2):185-90. PubMed ID: 7887461
[TBL] [Abstract][Full Text] [Related]
23. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
Escano J; Stauffer B; Brennan J; Bullock M; Smith L
Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
[TBL] [Abstract][Full Text] [Related]
24. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
25. Lantibiotics.
Gasson MJ
Biotechnology; 1995; 28():283-306. PubMed ID: 8688628
[No Abstract] [Full Text] [Related]
26. Post-translational modifications during lantibiotic biosynthesis.
Xie L; van der Donk WA
Curr Opin Chem Biol; 2004 Oct; 8(5):498-507. PubMed ID: 15450492
[TBL] [Abstract][Full Text] [Related]
27. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
[TBL] [Abstract][Full Text] [Related]
28. Methodologies and strategies for the bioengineering of lantibiotics.
Nagao J; Nishie M; Sonomot K
Curr Pharm Biotechnol; 2011 Aug; 12(8):1221-30. PubMed ID: 21470152
[TBL] [Abstract][Full Text] [Related]
29. Gene-encoded antibiotics made in bacteria.
Sahl HG
Ciba Found Symp; 1994; 186():27-42; discussion 42-53. PubMed ID: 7768156
[TBL] [Abstract][Full Text] [Related]
30. Lantibiotics: promising candidates for future applications in health care.
Dischinger J; Basi Chipalu S; Bierbaum G
Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
[TBL] [Abstract][Full Text] [Related]
31. Lantibiotics: peptides of diverse structure and function.
Willey JM; van der Donk WA
Annu Rev Microbiol; 2007; 61():477-501. PubMed ID: 17506681
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.
Repka LM; Chekan JR; Nair SK; van der Donk WA
Chem Rev; 2017 Apr; 117(8):5457-5520. PubMed ID: 28135077
[TBL] [Abstract][Full Text] [Related]
33. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
34. Biomimetic synthesis of lantibiotics.
Burrage S; Raynham T; Williams G; Essex JW; Allen C; Cardno M; Swali V; Bradley M
Chemistry; 2000 Apr; 6(8):1455-66. PubMed ID: 10840968
[TBL] [Abstract][Full Text] [Related]
35. Strategies for the isolation and characterization of antibacterial lantibiotics.
Jabes D; Donadio S
Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
[TBL] [Abstract][Full Text] [Related]
36. Biosynthesis and mode of action of lantibiotics.
Chatterjee C; Paul M; Xie L; van der Donk WA
Chem Rev; 2005 Feb; 105(2):633-84. PubMed ID: 15700960
[No Abstract] [Full Text] [Related]
37. Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors.
Moll GN; Kuipers A; Rink R; Bosma T; de Vries L; Namsolleck P
Biochem Soc Trans; 2020 Oct; 48(5):2195-2203. PubMed ID: 33125486
[TBL] [Abstract][Full Text] [Related]
38. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
[TBL] [Abstract][Full Text] [Related]
39. Lantibiotics produced by lactic acid bacteria: structure, function and applications.
Twomey D; Ross RP; Ryan M; Meaney B; Hill C
Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):165-85. PubMed ID: 12369187
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids.
Levengood MR; Kerwood CC; Chatterjee C; van der Donk WA
Chembiochem; 2009 Mar; 10(5):911-9. PubMed ID: 19222036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
